AstraZeneca CEO: 2020 Approval For COVID Vaccine Still Possible

Soriot Says Speed Has Not Compromised Safety

While AZ awaits an independent review, its CEO maintains the vaccine could soon be back on track for a late 2020/early 2021 approval.

Pascal Soriot
Soriot rejected allegations of a lack of transparency, and said the review was in the hands of an independent safety monitoring board.

More from Business

More from Scrip